Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yunfu Lv

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Journal of Cancer Research and Clinical Oncology|February 9, 2010
Gastrin-releasing peptide links stressor to cancer progressionXinqiu Li, Yunfu Lv, Aihua Yuan, et al.
Experimental Biology and Medicine (Maywood, N.J.)|November 10, 2020
Etiological classification and treatment strategies for secondary bile duct dilatationYunfu Lv, Ning Liu, Hongfei Wu, et al.
Archives of Medical Science : AMS|September 21, 2023
Expression of CXCL12-CXCR4/CXCR7 chemokines in splenic fibrosis of cirrhotic spleen and its therapeutic significanceYunfu Lv, Yejuan Li, XiaoYu Han, et al.
The Journal of International Medical Research|December 20, 2019
Investigation into imbalance of Th1/Th2 cells in cirrhotic, hypersplenic ratsYunfu Lv, Yejuan Li, Ning Liu, et al.
Cell Biochemistry and Biophysics|April 4, 2014
Clinical study on the relationship between hematocytopenia and splenomegaly caused by cirrhotic portal hypertensionYunfu Lv, Xiaoguang Gong, Xianhe Xie, et al.
Oncology Reports|July 3, 2010
Gastrin-releasing peptide promotes the growth of HepG2 cells via EGFR-independent ERK1/2 activationXinqiu Li, Yunfu Lv, Aihua Yuan, et al.
Scientific Reports|October 29, 2021
Impact of total splenectomy on peripheral lymphocytes and their subsets in patients with hypersplenism associated with cirrhotic portal hypertensionYunfu Lv, Hongfei Wu, Wan Yee Lau, et al.
Experimental and Therapeutic Medicine|June 16, 2018
Spontaneous remission of obstructive jaundice in rats: Selection of experimental modelsYunfu Lv, Jie Yue, Xiaoguang Gong, et al.
Disease Markers|June 16, 2023
Coagulation Dysfunction in Patients with Liver Cirrhosis and Splenomegaly and Its Countermeasures: A Retrospective Study of 1522 PatientsYunfu Lv, Ning Liu, Yejuan Li, et al.
Disease Markers|July 5, 2022
circIFT80 Functions as a ceRNA for miR-142, miR-568, and miR-634 and Promotes the Progression of Colorectal Cancer by Targeting <i>β</i>-CateninNing Liu, Fan Jiang, Zhiju Chen, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal of Cancer Research and Clinical Oncology|February 9, 2010
Gastrin-releasing peptide links stressor to cancer progressionXinqiu Li, Yunfu Lv, Aihua Yuan, et al.
Experimental Biology and Medicine (Maywood, N.J.)|November 10, 2020
Etiological classification and treatment strategies for secondary bile duct dilatationYunfu Lv, Ning Liu, Hongfei Wu, et al.
Archives of Medical Science : AMS|September 21, 2023
Expression of CXCL12-CXCR4/CXCR7 chemokines in splenic fibrosis of cirrhotic spleen and its therapeutic significanceYunfu Lv, Yejuan Li, XiaoYu Han, et al.
The Journal of International Medical Research|December 20, 2019
Investigation into imbalance of Th1/Th2 cells in cirrhotic, hypersplenic ratsYunfu Lv, Yejuan Li, Ning Liu, et al.
Cell Biochemistry and Biophysics|April 4, 2014
Clinical study on the relationship between hematocytopenia and splenomegaly caused by cirrhotic portal hypertensionYunfu Lv, Xiaoguang Gong, Xianhe Xie, et al.
Oncology Reports|July 3, 2010
Gastrin-releasing peptide promotes the growth of HepG2 cells via EGFR-independent ERK1/2 activationXinqiu Li, Yunfu Lv, Aihua Yuan, et al.
Scientific Reports|October 29, 2021
Impact of total splenectomy on peripheral lymphocytes and their subsets in patients with hypersplenism associated with cirrhotic portal hypertensionYunfu Lv, Hongfei Wu, Wan Yee Lau, et al.
Experimental and Therapeutic Medicine|June 16, 2018
Spontaneous remission of obstructive jaundice in rats: Selection of experimental modelsYunfu Lv, Jie Yue, Xiaoguang Gong, et al.
Disease Markers|June 16, 2023
Coagulation Dysfunction in Patients with Liver Cirrhosis and Splenomegaly and Its Countermeasures: A Retrospective Study of 1522 PatientsYunfu Lv, Ning Liu, Yejuan Li, et al.
Disease Markers|July 5, 2022
circIFT80 Functions as a ceRNA for miR-142, miR-568, and miR-634 and Promotes the Progression of Colorectal Cancer by Targeting <i>β</i>-CateninNing Liu, Fan Jiang, Zhiju Chen, et al.
Pageof 2